Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”
- Annual Bite Incidence
- 2.
- Probability of bite from a rabid animal
- 3.
- A one-way sensitivity analysis was conducted to test the uncertainty of the input variables on the outcomes of all the strategies tested in this modeling study. The upper and lower limits of data inputs were extracted from the literature for this study. The limits were set at varying degrees of variation as per the feasibility of values for the variables where additional data inputs were not available in the literature. The paper has already mentioned that the outcome of the study is sensitive to the variables on rabies positivity of the biting animal and animal bite incidence.
- 4.
- The limitations of the modelling study are clearly mentioned in the paper. We accept that there is a lack of nationally representative, age-specific data on animal bites and rabies in India. We have also disclosed the various assumptions taken due to the dearth of literature. The data inputs were extracted from the closely representative studies and were validated by the field experts.
- 5.
- The paper has been concluded with a suggestion to conduct studies in primary settings to extract data useful for future cost-effectiveness studies of shorter regimens in real-time settings. The shorter regimen of PrEP has been proven to be cost-effective in our model. As with any health economic model, it is always advised to extract data inputs from real-time settings and re-run the analysis for more realistic outcomes for any future cost-effectiveness analysis.
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88. Vaccines 2023, 11, 677. [Google Scholar] [CrossRef]
- Royal, A.; John, D.; Bharti, O.; Tanwar, R.; Bhagat, D.K.; Padmawati, R.S.; Chaudhary, V.; Umapathi, R.; Bhadola, P.; Utarini, A. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88. [Google Scholar] [CrossRef] [PubMed]
- John, D.; Royal, A.; Bharti, O. Burden of illness of dog-mediated rabies in India: A systematic review. Clin. Epidemiol. Glob. Health 2021, 12, 100804. [Google Scholar] [CrossRef]
- Association for Prevention Control of Rabies in India A. Indian Multicentric Rabies Survey—2017; Association for Prevention & Control of Rabies in India (APCRI): Bengaluru, India, 2018; Available online: http://apcri.in/pdf/WHO-APCRI%20Rabies%20Survey,%202017%20-%20Final%20Report.pdf (accessed on 26 March 2023).
- Sudarshan, M.K.; Mahendra, B.J.; Madhusudana, S.N.; Ashwoath Narayana, D.H.; Rahman, A.; Rao, N.S.; X-Meslin, F.; Lobo, D.; Ravikumar, K.; Gangaboraiah. An epidemiological study of animal bites in India: Results of a WHO sponsored national multi-centric rabies survey. J. Commun. Dis. 2006, 38, 32–39. [Google Scholar] [PubMed]
- Goel, K.; Sen, A.; Satapathy, P.; Kumar, P.; Aggarwal, A.K.; Sah, R.; Padhi, B.K. Emergence of rabies among vaccinated humans in India: A public health concern. Lancet Reg. Health Southeast Asia 2023, 9, 100109. [Google Scholar] [CrossRef]
- Shewale, A.; Nale, T.; Daptardar, M.; Tiwari, S. A Case for Pre-Exposure Prophylaxis of High-Risk Groups against Rabies in India. J. Commun. Dis. 2021, 53, 110–116. [Google Scholar] [CrossRef]
- Quiambao, B.; Varghese, L.; Demarteau, N.; Sengson, R.; Javier, J.; Mukherjee, P.; Manio, L.C.; Preiss, S. Health economic assessment of a rabies pre-exposure prophylaxis program compared to post-exposure prophylaxis alone in high-risk age groups in the Philippines. Int. J. Infect. Dis. 2020, 97, 38–46. [Google Scholar] [CrossRef] [PubMed]
- Caro, J.J.; Briggs, A.H.; Siebert, U.; Kuntz, K.M. ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling good research practices—Overview: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force—1. Value Health 2012, 15, 796–803. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agarwal, N.; Singh, C.; Gulsha, K.; Singh, S.; Sinha, S.; Singh, K.; Singh, G. Epidemiology of dog bites in Patna: A cross sectional study. Indian J. Community Fam. Med. 2015, 1, 70–74. [Google Scholar]
- Husereau, D.; Drummond, M.; Augustovski, F.; de Bekker-Grob, E.; Briggs, A.H.; Carswell, C.; Caulley, L.; Chaiyakunapruk, N.; Greenberg, D.; Loder, E.; et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Explanation and Elaboration: A report of the ISPOR CHEERS II Good Practices Task Force. Value Health 2022, 25, 10–31. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Royal, A.; John, D.; Bharti, O.; Tanwar, R.; Bhagat, D.K.; Padmawati, R.S.; Chaudhary, V.; Umapathi, R.; Bhadola, P.; Utarini, A. Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”. Vaccines 2023, 11, 807. https://doi.org/10.3390/vaccines11040807
Royal A, John D, Bharti O, Tanwar R, Bhagat DK, Padmawati RS, Chaudhary V, Umapathi R, Bhadola P, Utarini A. Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”. Vaccines. 2023; 11(4):807. https://doi.org/10.3390/vaccines11040807
Chicago/Turabian StyleRoyal, Abhishek, Denny John, Omesh Bharti, Ritesh Tanwar, Deepak Kumar Bhagat, Retna Siwi Padmawati, Vishal Chaudhary, Reddicherla Umapathi, Pradeep Bhadola, and Adi Utarini. 2023. "Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”" Vaccines 11, no. 4: 807. https://doi.org/10.3390/vaccines11040807
APA StyleRoyal, A., John, D., Bharti, O., Tanwar, R., Bhagat, D. K., Padmawati, R. S., Chaudhary, V., Umapathi, R., Bhadola, P., & Utarini, A. (2023). Reply to Kapur, V. Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on “Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11, 88”. Vaccines, 11(4), 807. https://doi.org/10.3390/vaccines11040807